Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Shares Outstanding (Weighted Average): 2019-2023

Historic Shares Outstanding (Weighted Average) for ADC Therapeutics (ADCT) over the last 4 years, with Dec 2023 value amounting to $82.3 million.

  • ADC Therapeutics' Shares Outstanding (Weighted Average) rose 2.23% to $82.3 million in Q4 2023 from the same period last year, while for Sep 2023 it was $81.5 million, marking a year-over-year change of. This contributed to the annual value of $96.7 million for FY2024, which is 17.55% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Shares Outstanding (Weighted Average) is $82.3 million, which was up 0.96% from $81.5 million recorded in Q3 2023.
  • ADC Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $82.3 million during Q4 2023, with a 5-year trough of $66.9 million in Q4 2019.
  • Over the past 3 years, ADC Therapeutics' median Shares Outstanding (Weighted Average) value was $76.9 million (recorded in 2022), while the average stood at $78.6 million.
  • Data for ADC Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY rose of 14.73% (in 2021) over the last 5 years.
  • ADC Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $66.9 million in 2019, then reached $70.9 million in 2020, then grew by 8.20% to $76.7 million in 2021, then rose by 4.85% to $80.5 million in 2022, then climbed by 2.23% to $82.3 million in 2023.
  • Its last three reported values are $82.3 million in Q4 2023, $81.5 million for Q3 2023, and $80.8 million during Q2 2023.